drugset / Trial / NCT02294149
Vit D3 and Omega 3 in Chemo Induced Neuropathy
Phase 3
Unknown
600 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to determine whether administration of mammalian Omega 3 FA(fatty acid) with Vitamin D3 supplements would lower or prevent the risk of neuropathy due to chemotherapy.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-04
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | — | Other |
| Subject | mammalian Omega 3 Fatty acids | Other / unclassified | — | Other |